Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Vipshop Reports Unaudited Third Quarter 2024 Financial Results 2024-11-19 18:00
Noah to Host Corporate Open Day on December 6, 2024, in Hong Kong 2024-11-19 17:35
Weibo Announces Third Quarter 2024 Unaudited Financial Results 2024-11-19 17:15
SiPH Collaborates with IBM to Enhance Pathology Information System with Computational Advances and AI to Support Patients in Thailand and ASEAN 2024-11-19 17:07
Willog Awarded 'Minister of Land, Infrastructure, and Transport Citation' at Korea Logistics Awards for the Third Consecutive Time 2024-11-19 16:10
Clarivate Reveals Highly Cited Researchers 2024 List 2024-11-19 16:00
Gaotu Techedu to Report Third Quarter 2024 Financial Results on December 4, 2024 2024-11-19 16:00
Hyundai Mobis Outlines Value-Up Strategy at CEO Investor Day 2024-11-19 14:15
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025 2024-11-19 10:42
Ribbon Strengthens Commitment to Thai Market with Expanded Manufacturing 2024-11-19 10:14
Zepp Health Corporation Reports Third Quarter 2024 Unaudited Financial Results 2024-11-19 09:00
SK Biopharmaceuticals Seals 1st Actinium-225-Based Collaborative Research Agreement with Korea Institute of Radiological and Medical Sciences as Steps Toward Becoming Global Radiopharmaceutical Therapy Player 2024-11-19 08:00
Everest Medicines Announces NEFECON® Has Received Full Approval from South Korea's Ministry of Food and Drug Safety (MFDS) for the Treatment of Primary IgA Nephropathy 2024-11-19 07:40
Telix to Add FAP-Targeting Candidates to Theranostic Pipeline 2024-11-19 06:24
FinVolution Group Reports Third Quarter 2024 Unaudited Financial Results 2024-11-19 06:00
Trip.com Group Limited Reports Unaudited Third Quarter of 2024 Financial Results 2024-11-19 06:00
Tuya Reports Third Quarter 2024 Unaudited Financial Results 2024-11-19 05:05
Supermicro Delivers Direct-Liquid-Optimized NVIDIA Blackwell Solutions 2024-11-19 02:35
Celltrion presents additional data from phase III randomized controlled trials to further support biosimilarity for CT-41 (biosimilar candidate of denosumab) and CT-P47 (biosimilar candidate of tocilizumab) at American College of Rheumatology (ACR) Convergence 2024 2024-11-19 02:15
Aon Launches Cyber Risk Analyzer to Mitigate Clients' Cyber Risk Exposure 2024-11-18 23:00
1 3 4 5 6 7 3393